Company Quick10K Filing
Nevada Gold & Casinos
10-Q 2019-01-31 Filed 2019-03-18
10-Q 2018-10-31 Filed 2018-12-17
10-Q 2018-07-31 Filed 2018-09-13
10-K 2018-04-30 Filed 2018-07-26
10-Q 2018-01-31 Filed 2018-03-19
10-Q 2017-10-31 Filed 2017-12-14
10-Q 2017-07-31 Filed 2017-09-14
10-K 2017-04-30 Filed 2017-07-27
10-Q 2017-01-31 Filed 2017-03-16
10-Q 2016-10-31 Filed 2016-12-15
10-Q 2016-07-31 Filed 2016-09-14
10-K 2016-04-30 Filed 2016-07-29
10-Q 2016-01-31 Filed 2016-03-16
10-Q 2015-10-31 Filed 2015-12-15
10-Q 2015-07-31 Filed 2015-09-14
10-K 2015-04-30 Filed 2015-07-27
10-Q 2015-01-31 Filed 2015-03-17
10-Q 2014-10-31 Filed 2014-12-15
10-Q 2014-07-31 Filed 2014-09-15
10-K 2014-04-30 Filed 2014-07-29
10-Q 2014-01-31 Filed 2014-03-21
10-Q 2013-10-31 Filed 2013-12-23
10-K 2013-04-30 Filed 2013-07-29
10-Q 2013-01-31 Filed 2013-03-12
10-Q 2012-10-31 Filed 2012-12-12
10-Q 2012-07-31 Filed 2012-09-12
10-K 2012-04-30 Filed 2012-07-27
10-Q 2012-01-31 Filed 2012-03-16
10-Q 2011-10-31 Filed 2011-12-15
10-Q 2011-07-31 Filed 2011-09-14
10-K 2011-04-30 Filed 2011-07-14
10-Q 2011-01-31 Filed 2011-03-16
10-Q 2010-10-31 Filed 2010-12-14
10-Q 2010-07-31 Filed 2010-09-14
10-K 2010-04-30 Filed 2010-07-29
10-Q 2010-01-31 Filed 2010-03-17
8-K 2019-06-14
8-K 2019-05-06
8-K 2019-03-20
8-K 2019-02-22
8-K 2019-02-01
8-K 2018-12-31
8-K 2018-11-29
8-K 2018-09-18
8-K 2018-08-03
8-K 2018-06-27
8-K 2018-05-23
8-K 2018-05-02

Nevada Gold & Casinos Financials

UWN Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
Ameren Illinois Co (AILNP)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
Bioquest Corp (BQST)
30DC (TDCH)
BriaCell Therapeutics Corp. (BCTXW)
DD3 Acquisition Corp. II (DDMXW)
3D Total Solutions (DTLS)
3DX Industries (DDDX)
8i Acquisition 2 Corp. (LAX)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-07-312011-10-312012-01-312012-04-302012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-31
Cash5,3543,7435,2385,2005,8696,7886,7247,1986,8445,6877,7398,2897,7727,4558,5427,15414,1608,82211,5838,82610,2389,58410,6328,2869,5598,5999,50910,94112,51120,306
Accounts Receivable6725485176534363244457574123682536833845522977586397686661,192469363808837398363486298291670
Inventory
PP&E5,0393,9535,5995,3995,3045,1977,6284,8774,7294,4997,9224,1934,3714,1818,4423,8443,79415,43220,78921,44821,50721,56321,59421,85222,10622,28522,0739,4809,5149,536
Assets50,48348,33654,73549,17348,24247,65446,52447,30145,70344,02244,80745,76444,28843,08543,14343,40343,40958,74157,75955,75455,34552,51252,81850,63150,54648,81849,12347,64949,11442,930
Accounts Payable
Long-Term Debt15,42615,34016,86516,55515,57514,75014,21014,84013,92012,75012,35011,95010,2008,8007,3508,1496,74018,74017,17316,54815,50014,00012,30012,30010,6009,3008,0006,9006,9000
Liabilities19,48419,40122,11721,78721,34720,44018,81719,77917,91616,40716,48017,05715,11613,39412,71812,31311,61324,19823,39021,44321,13819,12018,30617,60816,91114,94714,87013,46814,3806,149
Stockholders' Equity30,99928,93532,61927,38626,89627,21427,70727,52327,78727,61528,32728,70729,17129,69130,42531,09131,79634,54334,36934,31134,20733,39234,51233,02333,63533,87234,25334,18134,73436,781
Income Statement ($'000)2011-07-312011-10-312012-01-312012-04-302012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-31
Revenue14,15912,83313,47716,56816,38416,21016,51915,69116,34914,77615,99115,90917,52015,80416,26415,94316,13418,36119,90318,29718,54317,98719,80018,48919,48018,09818,48614,88014,35414,564
Cost of Revenue8688577778048158107968198508498357788781,2161,7861,5951,6541,5571,5291,5461,5111,4841,474
Gross Profit15,51615,35315,74314,88715,53513,96615,19515,08916,67014,95515,42915,16515,25617,14418,11716,70216,88916,43018,27116,94317,96916,61417,011
R&D
SG&A4,5304,0184,1214,3554,0124,1034,1524,3104,0774,0333,9504,1134,2334,2564,3814,1414,0424,8245,2665,2705,6115,1505,3365,2875,2965,3794,7544,4754,3944,396
Tax-98-1,040-57-1,970-108369211-158115-73399153425240293228301284409-487119057860260398135249812
Net Income-192-2,121-288-5,328-819235452-216221-203646354973448589458618466-241-100150-6831,197124639193367-52539-121
Cash Flow ($'000)2011-07-312011-10-312012-01-312012-04-302012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-31
Cash Operating809-3491,4602121,324-1,393-1006194102,4149801,0202,375-9692,7857943,762-1,7062,6829742,805-5453692,399361,476
Cash Investing-1,061-262-3,487-11392142-49-8335-13-433749-1,222-42-12,330534-439122525-182-38-189129100
Cash Financing-50-1,0003,522-239-7971,187623-890-1,602-349-388-1,373-1,337803-1,38311,846-1,535-612-1,392-1,632-1,782-1,618-1,292-1,300-1,1000